Feature Article

ICON plc, a provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, has announced the appointment of Alan Morgan to the position of Group President, Clinical Research Services. Morgan is currently Group President, ICON Early Phase and Laboratory Services, and prior to that was Chief Operating Officer of the ICON Clinical Research division, having joined ICON in 2006. He has over 20 years experience working in both the pharmaceutical and the CRO industries. Prior to joining ICON, he was Vice President and Global General Manager of the Phase II/IV business of MDS Pharma Services, and he has also held senior positions in Covance, Glaxo Wellcome and ICI Pharmaceuticals.